102,212 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Bought by Vestor Capital LLC

Vestor Capital LLC purchased a new position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 102,212 shares of the company's stock, valued at approximately $13,538,000. Astera Labs makes up approximately 1.0% of Vestor Capital LLC's portfolio, making the stock its 24th biggest holding. Vestor Capital LLC owned 0.06% of Astera Labs at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Tidal Investments LLC increased its stake in Astera Labs by 81.8% during the 3rd quarter. Tidal Investments LLC now owns 45,298 shares of the company's stock worth $2,373,000 after purchasing an additional 20,388 shares in the last quarter. Proficio Capital Partners LLC increased its position in shares of Astera Labs by 1.8% during the fourth quarter. Proficio Capital Partners LLC now owns 21,626 shares of the company's stock worth $2,864,000 after acquiring an additional 390 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Astera Labs during the third quarter worth $530,000. Avior Wealth Management LLC acquired a new stake in shares of Astera Labs during the third quarter worth $361,000. Finally, Maverick Capital Ltd. lifted its position in Astera Labs by 16.0% in the 3rd quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company's stock valued at $60,575,000 after acquiring an additional 159,480 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company's stock.

Astera Labs Trading Down 7.3 %

NASDAQ:ALAB traded down $5.24 on Wednesday, hitting $66.95. The company's stock had a trading volume of 3,010,451 shares, compared to its average volume of 3,640,962. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $147.39. The firm has a market capitalization of $10.86 billion and a P/E ratio of -38.70. The stock has a fifty day moving average of $89.05 and a two-hundred day moving average of $90.03.

Remove Ads

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling

In other news, General Counsel Philip Mazzara sold 7,536 shares of Astera Labs stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $92.07, for a total transaction of $693,839.52. Following the completion of the sale, the general counsel now owns 241,209 shares of the company's stock, valued at approximately $22,208,112.63. This trade represents a 3.03 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Michael Truett Tate sold 34,474 shares of the business's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $92.07, for a total transaction of $3,174,021.18. Following the completion of the sale, the chief financial officer now directly owns 244,242 shares of the company's stock, valued at approximately $22,487,360.94. The trade was a 12.37 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 570,990 shares of company stock valued at $50,242,702.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of research reports. Raymond James assumed coverage on Astera Labs in a report on Friday, March 14th. They issued an "outperform" rating and a $82.00 price target on the stock. Needham & Company LLC restated a "buy" rating and issued a $140.00 target price on shares of Astera Labs in a research note on Tuesday, February 11th. Northland Capmk raised shares of Astera Labs from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, January 28th. Craig Hallum boosted their price objective on shares of Astera Labs from $105.00 to $125.00 and gave the stock a "buy" rating in a research report on Tuesday, February 11th. Finally, Northland Securities raised shares of Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 target price for the company in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Astera Labs presently has an average rating of "Buy" and a consensus target price of $112.77.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.